HTAC GUIDANCE: PNF INCLUSION OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPOETIN ALFA) 4000 IU/ML SOLUTION FOR INJECTION (IV/SC) 1ML PRE-FILLED SYRINGE
HTAC GUIDANCE: PNF INCLUSION OF FILGRASTIM 300 MCG/0.9 ML SOLUTION (IV, SC), 0.9 ML PRE-FILLED SYRINGE
[ANNOUNCEMENT] CEREMONIAL TURNOVER OF HTA IMPLEMENTATION FROM THE DEPARTMENT OF HEALTH TO THE DEPARTMENT OF SCIENCE AND TECHNOLOGY
[ANNOUNCEMENT] HTA COUNCIL RELEASES ITS PRELIMINARY RECOMMENDATION ON THE FINANCING OF DAPAGLIFLOZIN FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS
[ANNOUNCEMENT] HTAC RELEASES ITS ADVISORY ON THE ANNOUNCEMENT FOR THE CALL FOR NOMINATIONS FOR THE GENERAL TRACK ASSESSMENT FOR 2024
Evidence Summary on AstraZeneca COVID-19 vaccine as Second Booster/ Fourth Dose for the prevention of COVID-19
